Ibio Inc Stock News

During the recent session, iBio Inc. (AMEX:IBIO)s traded shares were 1.73 million, with the beta value of the company hitting -6.05. At the last check today, the stocks price was $0.69, reflecting an intraday gain of 4.19% or $0.02. The 52-week high for the IBIO share is $2.83, that puts it down -310.14 from that Do You Still Have A Reason To Buy iBio Inc. (AMEX: IBIO) After A -5.29% Drop In The Last Week? Read More »

Hot penny stocks to watch as new virus fears emerge on Black Friday. The post Hot Penny Stocks To Buy? 7 To Watch As African Variant Shakes Markets appeared first on Penny Stocks to Buy, Picks, News a

Hot penny stocks to watch as new virus fears emerge on Black Friday. The post Hot Penny Stocks To Buy?

Wells Fargo & Company (WFC) with the stream of -2.16% also noticed, India iBio, Inc. (IBIO) encountered a rapid change of 2.18% in the last hour of Friday’s trading session. … The post Hot Stock Evaluation: NIO Inc. (NYSE:NIO), Northern Dynasty Minerals Ltd. (AMEX:NAK) appeared first on Stocks Equity .

iBio, Inc. (NYSEAMERICAN:IBIO) was the target of a large drop in short interest in October. As of October 29th, there was short interest totalling 11,450,000 shares, a drop of 22.2% from the October 14th total of 14,720,000 shares. Currently, 5.3% of the companys stock are sold short. Based on an average daily volume of 3,090,000 []

iBio, Inc. (NYSEAMERICAN:IBIO) was the target of a significant decrease in short interest in the month of October. As of October 29th, there was short interest totalling 11,450,000 shares, a decrease of 22.2% from the October 14th total of 14,720,000 shares. Based on an average trading volume of 3,090,000 shares, the days-to-cover ratio is presently []

iBio Inc. (AMEX:IBIO)s traded shares stood at 0.96 million during the latest session, with the companys beta value hitting -6.03. At the last check today, the stocks price was $0.70, to imply an increase of 6.67% or $0.04 in intraday trading. The IBIO shares 52-week high remains $2.83, putting it -304.29% down since that peak iBio Inc. (AMEX: IBIO) Surged -55.10% In 6 Months Heres What Happens Next Read More »

Schonfeld Strategic Advisors LLC acquired a new position in iBio, Inc. (NYSEAMERICAN:IBIO) during the second quarter, Holdings Channel reports. The institutional investor acquired 37,700 shares of the biotechnology companys stock, valued at approximately $57,000. A number of other large investors have also recently added to or reduced their stakes in IBIO. UBS Group AG increased []

BRYAN, Texas, Nov. 17, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-bas

BRYAN, Texas, Nov. 17, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (iBio or the Company), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System ® , announced today that Glass Lewis and Co., LLC (Glass Lewis), a leading independent provider of proxy research and vote recommendations to the investment community, has recommended that the Companys stockholders vote FOR all proposals put forth in the definitive proxy statement prior to its Annual Meeting of Stockholders to be held on December 9, 2021.

Walmart Inc. (WMT) with the stream of -0.81% also noticed, India iBio, Inc. (IBIO) encountered a rapid change of -4.01% in the last hour of Tuesdays trading session. Walmart Inc. The post Do the Stock Experienced Heavy Trading? Walmart Inc. (NYSE:WMT), iBio, Inc. (AMEX:IBIO) appeared first on Stocks Equity .

In the latest trading session, 2.32 million iBio Inc. (AMEX:IBIO) shares changed hands as the companys beta touched -6.03. With the companys most recent per share price at $0.70 changed hands at -$0.05 or -6.19% at last look, the market valuation stands at $166.38M. IBIOs current price is a discount, trading about -304.29% off its iBio Inc. (IBIO) Will Continue To Grow In 2021. Read More »

iBio (NYSEAMERICAN:IBIO) announced its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, beating analysts consensus estimates of ($0.05) by $0.01, MarketWatch Earnings reports. iBio had a negative net margin of 978.78% and a negative return on equity of 33.34%. IBIO traded down $0.04 during trading on Tuesday, []

iBio, Inc. (IBIO) CEO Thomas Isett on Q3 2021 Results - Earnings Call Transcript